Bile acids regulate cardiovascular function

Sandeep Khurana, Jean Pierre Raufman, Thomas L. Pallone

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

Research over the last decade has uncovered roles for bile acids (BAs) that extend beyond their traditional functions in regulating lipid digestion and cholesterol metabolism. BAs are now recognized as signaling molecules that interact with both plasma membrane and nuclear receptors. Emerging evidence indicates that by interacting with these receptors, BAs regulate their own synthesis, glucose and energy homeostasis, and other important physiological events. Herein, we provide a comprehensive review of the actions of BAs on cardiovascular function. In the heart and the systemic circulation, BAs interact with plasma membrane G-protein-coupled receptors, for example, TGR5 and muscarinic receptors, and nuclear receptors, for example, the farnesoid (FXR) and pregnane (PXR) xenobiotic receptors. BA receptors are expressed in cardiovascular tissue, however, the mechanisms underlying BA-mediated regulation of cardiovascular function remain poorly understood. BAs reduce heart rate by regulating channel conductance and calcium dynamics in sino-atrial and ventricular cardiomyocytes and regulate vascular tone via both endothelium-dependent and -independent mechanisms. End-stage liver disease, obstructive jaundice, and intrahepatic cholestasis of pregnancy are prominent conditions in which elevated serum BAs alter vascular dynamics. This review focuses on BAs as newly recognized signaling molecules that modulate cardiovascular function.

Original languageEnglish (US)
Pages (from-to)210-218
Number of pages9
JournalClinical and Translational Science
Volume4
Issue number3
DOIs
StatePublished - Jun 1 2011

Fingerprint

Bile Acids and Salts
Cell membranes
Cytoplasmic and Nuclear Receptors
Blood Vessels
Cell Membrane
Pregnanes
End Stage Liver Disease
Molecules
Obstructive Jaundice
Muscarinic Receptors
Xenobiotics
Calcium Channels
G-Protein-Coupled Receptors
Cardiac Myocytes
Metabolism
Liver
Endothelium
Blood Proteins
Digestion
Membrane Proteins

Keywords

  • Arteries
  • Bile acids
  • Cardiomyocyte
  • Cirrhosis
  • Endothelium
  • Potassium channels
  • Receptors
  • Vascular tone

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Bile acids regulate cardiovascular function. / Khurana, Sandeep; Raufman, Jean Pierre; Pallone, Thomas L.

In: Clinical and Translational Science, Vol. 4, No. 3, 01.06.2011, p. 210-218.

Research output: Contribution to journalReview article

Khurana, Sandeep ; Raufman, Jean Pierre ; Pallone, Thomas L. / Bile acids regulate cardiovascular function. In: Clinical and Translational Science. 2011 ; Vol. 4, No. 3. pp. 210-218.
@article{4067b98cc37941e3aac1f61d62590554,
title = "Bile acids regulate cardiovascular function",
abstract = "Research over the last decade has uncovered roles for bile acids (BAs) that extend beyond their traditional functions in regulating lipid digestion and cholesterol metabolism. BAs are now recognized as signaling molecules that interact with both plasma membrane and nuclear receptors. Emerging evidence indicates that by interacting with these receptors, BAs regulate their own synthesis, glucose and energy homeostasis, and other important physiological events. Herein, we provide a comprehensive review of the actions of BAs on cardiovascular function. In the heart and the systemic circulation, BAs interact with plasma membrane G-protein-coupled receptors, for example, TGR5 and muscarinic receptors, and nuclear receptors, for example, the farnesoid (FXR) and pregnane (PXR) xenobiotic receptors. BA receptors are expressed in cardiovascular tissue, however, the mechanisms underlying BA-mediated regulation of cardiovascular function remain poorly understood. BAs reduce heart rate by regulating channel conductance and calcium dynamics in sino-atrial and ventricular cardiomyocytes and regulate vascular tone via both endothelium-dependent and -independent mechanisms. End-stage liver disease, obstructive jaundice, and intrahepatic cholestasis of pregnancy are prominent conditions in which elevated serum BAs alter vascular dynamics. This review focuses on BAs as newly recognized signaling molecules that modulate cardiovascular function.",
keywords = "Arteries, Bile acids, Cardiomyocyte, Cirrhosis, Endothelium, Potassium channels, Receptors, Vascular tone",
author = "Sandeep Khurana and Raufman, {Jean Pierre} and Pallone, {Thomas L.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1111/j.1752-8062.2011.00272.x",
language = "English (US)",
volume = "4",
pages = "210--218",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Bile acids regulate cardiovascular function

AU - Khurana, Sandeep

AU - Raufman, Jean Pierre

AU - Pallone, Thomas L.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Research over the last decade has uncovered roles for bile acids (BAs) that extend beyond their traditional functions in regulating lipid digestion and cholesterol metabolism. BAs are now recognized as signaling molecules that interact with both plasma membrane and nuclear receptors. Emerging evidence indicates that by interacting with these receptors, BAs regulate their own synthesis, glucose and energy homeostasis, and other important physiological events. Herein, we provide a comprehensive review of the actions of BAs on cardiovascular function. In the heart and the systemic circulation, BAs interact with plasma membrane G-protein-coupled receptors, for example, TGR5 and muscarinic receptors, and nuclear receptors, for example, the farnesoid (FXR) and pregnane (PXR) xenobiotic receptors. BA receptors are expressed in cardiovascular tissue, however, the mechanisms underlying BA-mediated regulation of cardiovascular function remain poorly understood. BAs reduce heart rate by regulating channel conductance and calcium dynamics in sino-atrial and ventricular cardiomyocytes and regulate vascular tone via both endothelium-dependent and -independent mechanisms. End-stage liver disease, obstructive jaundice, and intrahepatic cholestasis of pregnancy are prominent conditions in which elevated serum BAs alter vascular dynamics. This review focuses on BAs as newly recognized signaling molecules that modulate cardiovascular function.

AB - Research over the last decade has uncovered roles for bile acids (BAs) that extend beyond their traditional functions in regulating lipid digestion and cholesterol metabolism. BAs are now recognized as signaling molecules that interact with both plasma membrane and nuclear receptors. Emerging evidence indicates that by interacting with these receptors, BAs regulate their own synthesis, glucose and energy homeostasis, and other important physiological events. Herein, we provide a comprehensive review of the actions of BAs on cardiovascular function. In the heart and the systemic circulation, BAs interact with plasma membrane G-protein-coupled receptors, for example, TGR5 and muscarinic receptors, and nuclear receptors, for example, the farnesoid (FXR) and pregnane (PXR) xenobiotic receptors. BA receptors are expressed in cardiovascular tissue, however, the mechanisms underlying BA-mediated regulation of cardiovascular function remain poorly understood. BAs reduce heart rate by regulating channel conductance and calcium dynamics in sino-atrial and ventricular cardiomyocytes and regulate vascular tone via both endothelium-dependent and -independent mechanisms. End-stage liver disease, obstructive jaundice, and intrahepatic cholestasis of pregnancy are prominent conditions in which elevated serum BAs alter vascular dynamics. This review focuses on BAs as newly recognized signaling molecules that modulate cardiovascular function.

KW - Arteries

KW - Bile acids

KW - Cardiomyocyte

KW - Cirrhosis

KW - Endothelium

KW - Potassium channels

KW - Receptors

KW - Vascular tone

UR - http://www.scopus.com/inward/record.url?scp=79959758214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959758214&partnerID=8YFLogxK

U2 - 10.1111/j.1752-8062.2011.00272.x

DO - 10.1111/j.1752-8062.2011.00272.x

M3 - Review article

VL - 4

SP - 210

EP - 218

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 3

ER -